cas 881674-56-2|| where to buy 5-(2-fluorophenyl)-1H-pyrrole-3-carbaldehyde

Product Name:5-(2-fluorophenyl)-1H-pyrrole-3-carbaldehyde

IUPAC Name:5-(2-fluorophenyl)-1H-pyrrole-3-carbaldehyde

Packing Unit	Available Stock	Price($)
CM198689-25g	in stock	țȬ
CM198689-100g	in stock	ǜưƎ

For R&D use only.

Inquiry Form

Chemical Name

CAS Number

Quantity*

Required Specifications*
(Assay %, Material Grade etc.)

Contact Name*

Contact Email*

Additional Notes

Verification code*

refresh

: CAS NO:881674-56-2; Molecular Formula:C11H8FNO; Melting Point:-; Smiles Code:O=CC1=CNC(C2=CC=CC=C2F)=C1; Density:

: Catalog Number:CM198689; Molecular Weight:189.19; Boiling Point:370.6±32.0°C at 760 mmHg; MDL No:MFCD11875867; Storage:Keep in a tight container and store at 2°C~8°C

: Pyrroles; Pyrrole is a five membered heterocyclic compound with the molecular formula of C4H5N. Pyrrole has a ring composed of four carbon atoms and one nitrogen atom. Pyrrole is easy to polymerize in the air. Pyrrole is the parent compound of many important biological substances (such as bile pigment, porphyrin and chlorophyll). Pyrrole scaffolds are widely used in biological and pharmaceutical fields. Pyrrole is a special heterocyclic scaffold, which exists in many natural products, drug molecules and pesticides, and has shown its application in materials science.; Pyrrole,Where to Buy Pyrroles-Chemenu; Pyrrole,Where to Buy Pyrroles; Pyrrole is a heterocyclic, aromatic, organic compound, a five-membered ring with the formula C 4H 4NH. It is a colorless volatile liquid that darkens readily upon exposure to air. Substituted derivatives are also called pyrroles, e.g., N-methylpyrrole.

: Vonoprazan; Nov. 01, 2023, FDA has approved VOQUEZNA (vonoprazan) tablets, a novel potassium-competitive acid blocker (PCAB), as a new treatment for adults for the healing of all grades of Erosive Esophagitis, also known as Erosive GERD (gastroesophageal reflux disease).
PCABs are a novel class of medicines that block acid secretion in the stomach, and VOQUEZNA is the first PCAB to be approved in the U.S. Vonoprazan has shown the potential to provide acid suppression that can achieve pH levels that are important in enhancing treatment effectiveness.